Automation Engineer I at Karius

Redwood City, California, United States

Apply Now

Not SpecifiedCompensation

Entry Level & New Grad, Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, Life Sciences, DiagnosticsIndustries

Requirements

Laboratory experience
Skilled in programming liquid handlers (Hamilton preferred)
Eager to learn and take on new challenges

Responsibilities

Upgrade instruments and software when applicable
Programming, developing, optimizing, and validating new automated methods
Help design and optimize automated workflows for high-throughput processing of clinical samples, library prep, and NGS
Assist with scoping out project needs for new automated methods
Work cross-functionally to ensure successful project execution and meeting deliverables on time
Interface with lab automation suppliers for service visits, installations, and other needs
Conduct manufacturing and experimental processes according to established SOPs
Document and develop new SOPs for new processes and validation reports for automated processes and contribute to regulatory submissions as needed
Support of automated CLIA diagnostic processes
Train lab personnel on the operation, maintenance, and troubleshooting of automated systems and provide technical support as needed
Work comfortably in a fast-paced, collaborative, startup environment
Staying updated on advancements in automation technologies, genomics, and infectious disease diagnostics to propose and implement innovative solutions
Troubleshoot technical issues related to automated systems, perform routine maintenance, and ensure compliance with regulatory standards and quality control measures
May be required to perform other duties as assigned

Skills

Automation

NGS

Liquid Handlers

Hamilton

Programming

Robotics

CLIA

Genomics

Laboratory

Data Analysis

Troubleshooting

Karius

Non-invasive diagnostic tests for infections

About Karius

Karius focuses on medical diagnostics for infectious diseases, offering the Karius Test, which detects over 1,000 pathogens from a single blood sample. This non-invasive test is quick and helps clinicians treat hospitalized patients by reducing the need for multiple invasive tests that can delay treatment. The Karius Test utilizes advanced genomics and artificial intelligence to identify microbial cell-free DNA (mcfDNA) in the bloodstream, providing insights into the pathogens responsible for infections. Karius sells these diagnostic tests to healthcare providers, aiming to offer a faster and less invasive alternative to traditional methods, ultimately saving lives and reducing healthcare costs. The company employs proprietary machine learning algorithms to analyze genomic data in real time, continuously updating its reference genome databases to enhance its diagnostic capabilities.

Redwood City, CaliforniaHeadquarters

2014Year Founded

$311.3MTotal Funding

SERIES_CCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Remote Work Options

Hybrid Work Options

Risks

Competition from AlphaFold 3 could overlap with Karius's genomic insights.

Rapid AI advancements by competitors may outpace Karius's technology.

Reliance on continuous funding rounds indicates potential financial instability.

Differentiation

Karius Test detects over 1,000 pathogens from a single blood sample.

The test uses advanced genomics and AI for rapid, non-invasive diagnostics.

Karius's proprietary algorithms analyze genomic data in real time.

Upsides

Karius secured $100M to expand its test beyond 400 U.S. hospitals.

FDA Breakthrough Device Designation boosts credibility and market potential.

Growing demand for non-invasive diagnostics aligns with Karius's offerings.

Land your dream remote job 3x faster with AI

Try Jobo Free